Thymidine analogue withdrawal for lipoatrophic patients... [AIDS. 2002] - PubMed

Supplemental Content

Related citations

Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. [Antivir Ther. 2004]
Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck-Smit B, Hulsebosch HJ, Nieuwkerk P, van Eeden A, Brinkman K, Lange J, et al. Antivir Ther. 2004 Jun; 9(3):385-93.
Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine. [J Acquir Immune Defic Syndr. 2005]
Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.
Cherry CL, Lal L, Thompson KA, McLean CA, Ross LL, Hernandez J, Wesselingh SL, McComsey G. J Acquir Immune Defic Syndr. 2005 Mar 1; 38(3):263-7.
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. [AIDS. 2004]
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.
Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J, et al. AIDS. 2004 Apr 30; 18(7):1029-36.
Review [Use of thymidine-sparing regimens in first-line therapy and in switches from thymidine analogues]. [Infez Med. 2005]
Review [Use of thymidine-sparing regimens in first-line therapy and in switches from thymidine analogues].
Borderi M. Infez Med. 2005 Sep; 13(3):139-46.
Review [Tenofovir as a strategy to avoid or limit adverse effects]. [Enferm Infecc Microbiol Clin. 2008]
Review [Tenofovir as a strategy to avoid or limit adverse effects].
Portilla J. Enferm Infecc Microbiol Clin. 2008 Jun; 26 Suppl 8:19-24.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing ther...
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.
AIDS. 2002 Dec 6 ;16(18):2489-91.

PubMed
Generation of FGF reporter transgenic zebrafish and their utility in chemical sc...
Generation of FGF reporter transgenic zebrafish and their utility in chemical screens.
BMC Dev Biol. 2007 Jun 6 ;7:62.

PubMed
Hepatitis C, interferon alfa, and depression.
Hepatitis C, interferon alfa, and depression.
Hepatology. 2000 Jun ;31(6):1207-11.

PubMed
Important messages in the 'post': recent discoveries in 5-HT neurone feedback co...
Important messages in the 'post': recent discoveries in 5-HT neurone feedback control.
Trends Pharmacol Sci. 2007 Dec ;28(12):629-36. Epub 2007 Nov 9 .

PubMed
Mucoepidermoid carcinoma of bronchus in a pediatric patient: (18)F-FDG PET findi...
Mucoepidermoid carcinoma of bronchus in a pediatric patient: (18)F-FDG PET findings.
Pediatr Radiol. 2007 Dec ;37(12):1278-82. Epub 2007 Oct 9 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information